National Scleroderma Foundation

The patient advocacy organization for scleroderma, founded in 1998, that funds peer reviewed research toward a cure while volunteers who live with the disease lead the support groups that carry people through it.

11named by National Scleroderma Foundation
62named by peers

Financial profile

National Scleroderma Foundation · EIN 52-1375827 · 501(c)(3)

Fiscal yearTotal revenueContributionsProgram servicesTotal expensesNet assetsYear end
FY2025$6,628,652$5,597,175$0$6,783,274$8,332,615Jun 2025
FY2024$4,941,722$3,912,611$0$6,956,852$8,353,197Jun 2024
FY2023$6,915,898$6,057,608$0$6,461,742$9,811,236Jun 2023
FY2022$4,581,467$4,462,430$0$6,210,712$8,549,621Jun 2022
FY2021$4,188,631$3,976,045$0$4,468,676$11,398,690Jun 2021
FY2020$3,811,707$3,405,450$128,846$5,012,061$9,514,379Jun 2020

Figures exactly as reported. A blank cell was blank on the form. The fiscal year links to the filing.

Something wrong here? Tell us what we missed.

Peer societies

Five societies National Scleroderma Foundation is read alongside.

Who backs National Scleroderma Foundation

Every company National Scleroderma Foundation names publicly as a supporter, exactly as published. Companies also named by other associations on Sociogene come first.

CompanySupport as publishedAlso named by
AbbVieMeeting sponsorAND AAD AAN AAO AAO +3
argenxCorporate partnerAAN AANEM ACR ANA ASA +3
AstraZenecaCorporate partnerAMCP AAAAI AAFP AAN AAPA +3
Boehringer IngelheimCorporate partnerAAD AAFP AAO AAPA AAHA +3
Bristol Myers SquibbCorporate partnerAMCP ARM AAD AAN AAPMR +3
MerckCorporate partnerAcademyHealth AEE AAFP AAO AAP +3
NovartisCorporate partnerADLM AAD AAN AACR AANEM +3
United TherapeuticsCorporate partnerAMCP ACCP ASE ATS GDCC +3
Mediar TherapeuticsCorporate partnerACR PFF
NkartaCorporate partnerACR
Adicet BioCorporate partnerOnly National Scleroderma Foundation, so far
Sources: 3 published lists, read October 2026

2026 National Scleroderma Conference Sponsors. Read October 8, 2026. Sponsors of the 2026 National Scleroderma Conference.

Our Partners. Read October 8, 2026. Corporate donors recognized by the National Scleroderma Foundation.

Scleroderma Research Grant Program supporters. Read October 8, 2026. Companies supporting the peer reviewed research grant program.

Something wrong here? Tell us what we missed.

Who backs National Scleroderma Foundation's peers, but not National Scleroderma Foundation

Companies named publicly by at least one of National Scleroderma Foundation's five peer societies, and not found in National Scleroderma Foundation's reviewed public records.

CompanySjögren's FoundationLRAPFFPHAMGFAPeers
AmgenGold MembersCorporate Leadership CirclePresenting Partners3 of 5
InsmedPublished as insmed logoBronze MembersGoldStrategic Partner3 of 5
Johnson & JohnsonPublished as J&J LogoGold MembersPlatinumPresenting Partners3 of 5
AccredoPublished as Accredo by EvernorthNational SilverBronze2 of 5
CVS SpecialtyNational GoldBronze2 of 5
EMD SeronoCorporate Leadership CircleSupporting Partners2 of 5
Evernorth Health ServicesPublished as Evernorth Health Services (Accredo)Strategic PartnerSupporting Partners2 of 5
GenentechNamedFounding Partner2 of 5
Gossamer BioSilverGold2 of 5
LiquidiaNational GoldGold2 of 5
PulmovantNamedCorporate Champion2 of 5
UCBCorporate Leadership CircleCollaborating Partners2 of 5
Vor BioPublished as Vor LogoBronze MembersSupporting Partners2 of 5
AerovatePeer Support1 of 5
AlexionPublished as Alexion (logo)Presenting Partners1 of 5
ArcellxPublished as Arcellx (logo)Supporting Partners1 of 5
AuriniaCorporate Leadership Circle1 of 5
Avalyn PharmaPublished as AvalynGold1 of 5
BayerBronze1 of 5
BiogenCorporate Leadership Circle1 of 5
BrainomixNamed1 of 5
Cabaletta BioCorporate Leadership Circle1 of 5
Calluna PharmaNamed1 of 5
Cartesian TherapeuticsPublished as Cartesian (logo)Collaborating Partners1 of 5
Catalyst PharmaceuticalsPublished as Catalyst LogoCollaborating Partners1 of 5
Celea TherapeuticsNamed1 of 5
ChiesiDeveloping Partner1 of 5
Contineum TherapeuticsNamed1 of 5
Corsair PharmaMember1 of 5
Cosette PharmaceuticalsPublished as Cosette LogoFriend of the Foundation1 of 5
Cullinan TherapeuticsPublished as Cullinan LogoBronze Members1 of 5
Cumberland PharmaceuticalsNamed1 of 5
Diagonal TherapeuticsStrategic Partner1 of 5
Endeavor BioMedicinesNational Bronze1 of 5
GSKCorporate Leadership Circle1 of 5
Halo BiosciencesMember1 of 5
Horizon PharmaCorporate Leadership Circle1 of 5
ImmunovantPublished as Immunovant (logo)Supporting Partners1 of 5
InfuCareRxPublished as InfuCareRx (logo)Supporting Partner1 of 5
Inhibikase TherapeuticsStrategic Partner1 of 5
Insilico MedicineNamed1 of 5
JanssenCorporate Leadership Circle1 of 5
LillyCorporate Leadership Circle1 of 5
Lupus News TodayNamed1 of 5
MannKindSilver1 of 5
Merck KGaAPublished as MERCK (logo), merckgroup.comCollaborating Partners1 of 5
MJH Life SciencesPublished as MJHNamed1 of 5
NMD PharmaPublished as NMD Pharma (logo)Supporting Partners1 of 5
OrsiniPublished as Orsini Rare Disease Pharmacy SolutionsNamed1 of 5
OtsukaPublished as Otsuka LogoSilver Members1 of 5
OxiWearMember1 of 5
PAhR TherapeuticsMember1 of 5
PfizerCorporate Leadership Circle1 of 5
RegeneronPublished as Regeneron (logo)Supporting Partners1 of 5
Rein TherapeuticsNamed1 of 5
Resolve TherapeuticsPublished as Resolve logoBronze Members1 of 5
RheumLiveNamed1 of 5
Rules-Based MedicinePublished as Rules-Based Medicine, an IQVIA businessNamed1 of 5
Trevi TherapeuticsSilver1 of 5
Vertex PharmaceuticalsPublished as Vertex (logo)Supporting Partners1 of 5
Vicore PharmaSilver1 of 5
WCBSNamed1 of 5

Something wrong here? Tell us what we missed.

The outside view

The patient advocacy organization for scleroderma, founded in 1998, that funds peer reviewed research toward a cure while volunteers who live with the disease lead the support groups that carry people through it.

  • Consensus
  • Build
  • Outward
  • Volunteer

Their shape

The Movement

Gathered around a cause, and built to move.

The Movement is mission-led and built to mobilize, organized around changing something in the world. Its gift is passion and external impact, its challenge is turning momentum into something that lasts.

Also reads toward The Village and The Frontier.

Strengths

→Real influence on the wider field.
→Members are motivated by a clear why.
→Quick to rally around what matters now.

Not an official page of National Scleroderma Foundation. Sociogene does not consult. Everything here comes from public sources, dated and linked. Something wrong here? Tell us what we missed.